本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Sierra Oncology Inc

54.99
0.0000
成交量:- -
成交額:4,744.65萬
市值:13.43億
市盈率:-8.34
高:54.99
開:54.99
低:54.99
收:54.99
52周最高:55.19
52周最低:14.91
股本:2,441.93萬
流通股本:1,342.05萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-6.5912
每股收益(LYR):-7.1427
淨資產收益率:-56.54%
總資產收益率:-32.85%
市淨率:5.13
市盈率(LYR):-7.70

資料載入中...

2022/07/11

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/07/01

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/07/01

重要事件披露

8-K - Current report
2022/07/01

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/01

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/01

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/01

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/01

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/01

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/01

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/01

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/01

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/01

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/06/29

重要事件披露

8-K - Current report
2022/06/22

重要事件披露

8-K - Current report
2022/06/01

重要事件披露

8-K - Current report
2022/05/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/06

重要事件披露

8-K - Current report
2022/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]